🚀 Big News from Cellis! 🚀 We are thrilled to announce that our project MISAME, submitted under the Swiss-Polish Cooperation Programme (“Swiss Funds” for Applied Research and Innovation) of The National Centre for Research and Development (NCBR), has been officially recommended for funding and achieved the highest score among all considered companies and institutions!
The project, titled “Understanding the mechanism of immune system activation and identifying the markers of the efficacy of innovative glioma macrophage therapy,” represents a significant step forward in the fight against gliomas.
This achievement highlights the dedication and expertise of our team at Cellis, alongside our esteemed partner, Universitätsspital Zürich.
Thank you to everyone who contributed to this success. We are eagerly awaiting the signing of the agreement and the official awarding of the funds. This is just the beginning, and we’re excited to continue pushing the boundaries of innovation in oncology!
#Cellis #Innovation #GliomaTherapy #Macrophages #OncologyResearch #Achievement
